Pharma Co. Verrica Faces Derivative Suit Over FDA Inspection

By Emilie Ruscoe · October 22, 2024, 8:58 PM EDT

Current and former officers and directors of dermatological medication maker Verrica Pharmaceuticals Inc. face a shareholder derivative action alleging the company concealed a "litany of issues" with a manufacturer's facility that...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

COHEN v. MANNING et al

Case Number

2:24-cv-05561

Court

Pennsylvania Eastern

Nature of Suit

Contract: Stockholders Suits

Date Filed

October 21, 2024